Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Cash from Financing Activities (2022 - 2026)

Indivior Pharmaceuticals has reported Cash from Financing Activities over the past 5 years, most recently at $7.0 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 141.18% year-over-year to $7.0 million; the TTM value through Mar 2026 reached -$6.0 million, up 90.48%, while the annual FY2025 figure was -$30.0 million, 70.59% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was $7.0 million at Indivior Pharmaceuticals, up from -$5.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $40.0 million in Q4 2024 and troughed at -$56.0 million in Q1 2024.
  • A 5-year average of -$17.1 million and a median of -$17.0 million in 2025 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 202.56% in 2024 and fell as far as 5000.0% in 2024.
  • Year by year, Cash from Financing Activities stood at -$29.0 million in 2022, then tumbled by 34.48% to -$39.0 million in 2023, then surged by 202.56% to $40.0 million in 2024, then tumbled by 112.5% to -$5.0 million in 2025, then skyrocketed by 240.0% to $7.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for INDV at $7.0 million in Q1 2026, -$5.0 million in Q4 2025, and -$3.0 million in Q3 2025.